PG

Pushpavalli Gusidi

Director Additional Director DIN 08655421
DIN 08655421 First appointment Dec 2019 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Pushpavalli Gusidi

Data last updated:

Pushpavalli Gusidi was an Additional Director at Audi Pharmaceuticals Private Limited (2019–2022). The company operates in Professional Services.

DIN 08655421
Primary Designation Additional Director
Industry Professional Services
First Appointment 02 Dec 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Audi Pharmaceuticals Private Limited U74120AP2016PTC098137
Additional Director02 Dec 20192016₹1 Lakh (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Audi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pushpavalli Gusidi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pushpavalli Gusidi

Pushpavalli Gusidi was first appointed on 02 Dec 2019 as Additional Director at Audi Pharmaceuticals Private Limited.

Pushpavalli Gusidi held 1 earlier board appointment: Audi Pharmaceuticals Private Limited (Additional Director, 02 Dec 2019 to 08 Sep 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available